During the past decade, Nanfang Hospital, Southern Medical University conducted 247 clinical trials. In the 10-year time frame, 247 clinical trials started and 18 clinical trials were completed, i.e. on average, 7.3% percent of trials that started reached the finish line to date. In the past 5 years, 153 clinical trials started and 10 clinical trials were completed. i.e. 6.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nanfang Hospital, Southern Medical University" #1 sponsor was "Nanfang Hospital of Southern Medical University" with 93 trials, followed by "Hoffmann-La Roche" with 21 trials sponsored, "BeiGene" with 9 trials sponsored, "Ascentage Pharma Group Inc." with 8 trials sponsored and "Beijing Friendship Hospital" with 8 trials sponsored. Other sponsors include 144 different institutions and companies that sponsored additional 99 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nanfang Hospital, Southern Medical University" #1 collaborator was "Nanfang Hospital of Southern Medical University" with 27 trials as a collaborator, "Peking University People's Hospital" with 11 trials as a collaborator, "Beijing 302 Hospital" with 10 trials as a collaborator, "Beijing YouAn Hospital" with 9 trials as a collaborator and "Ruijin Hospital" with 8 trials as a collaborator. Other collaborators include 590 different institutions and companies that were collaborators in the rest 349 trials.

According to Clinical.Site data, the most researched conditions in "Nanfang Hospital, Southern Medical University" are "Gastric Cancer" (7 trials), "Hemophilia A" (7 trials), "Hepatocellular Carcinoma" (7 trials), "Hepatitis B, Chronic" (6 trials) and "Colorectal Cancer" (5 trials). Many other conditions were trialed in "Nanfang Hospital, Southern Medical University" in a lesser frequency.

Most popular intervention types in "Nanfang Hospital, Southern Medical University" are "Drug" (174 trials), "Procedure" (41 trials), "Other" (30 trials), "Device" (19 trials) and "Biological" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Atezolizumab" (9 trials), "Cisplatin" (7 trials), "Lenvatinib" (5 trials) and "Tislelizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Nanfang Hospital, Southern Medical University" are 267 trials for "All" genders, 11 trials for "Male" genders and 10 trials for "Female" genders.

Currently, there are 143 active trials in "Nanfang Hospital, Southern Medical University". 8 are not yet recruiting, 104 are recruiting, 29 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 73 completed trials in Nanfang Hospital, Southern Medical University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nanfang Hospital, Southern Medical University, 17 "Phase 1" clinical trials were conducted, 70 "Phase 2" clinical trials and 84 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 57 trials that are defined as “Not Applicable".

Nanfang Hospital, Southern Medical University has several departments that took part in Clinical trials: "Renal Division, Nanfang Hospital,Southern Medical University" - 3 trials